QuadMedicine Overview
- Year Founded
-
2016
- Status
-
Public
- Employees
-
86
- Stock Symbol
-
464490
- Share Price
-
$2.96
- (As of Friday Closing)
QuadMedicine General Information
Description
QuadMedicine Inc is engaged in developing pharmaceutical microneedles. The company focuses on a drug delivery system using microneedle technology that enables the transdermal delivery of vaccines and synthetic drugs, replacing intramuscular and subcutaneous injections.
Contact Information
Website
www.quadmedicine.comCorporate Office
- 605, Building B 14 Sagimakgol-Ro
- 45Beon-Gil, Jungwon-gu
- Seongnam, Gyeonggi 13209
- South Korea
Corporate Office
- 605, Building B 14 Sagimakgol-Ro
- 45Beon-Gil, Jungwon-gu
- Seongnam, Gyeonggi 13209
- South Korea
QuadMedicine Stock Performance
As of 13-Nov-2026, QuadMedicine’s stock price is $2.96. Its current market cap is $33.5M with 11.3M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.96 | $3.16 | $2.76 - $18.39 | $33.5M | 11.3M | 34.6K |
QuadMedicine Financials Summary
As of 31-Dec-2024, QuadMedicine has a trailing 12-month revenue of $6.82M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| Revenue | 6,816 | 6,816 | 774 | 1,647 |
| Total Assets | 19,570 | 14,860 | ||
| Total Debt | 0 | 0 |
QuadMedicine Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
QuadMedicine Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
QuadMedicine Patents
QuadMedicine Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260083949-A1 | Microneedle patch and method for manufacturing the same | Pending | 24-Sep-2024 | ||
| US-20250072797-A1 | Microneedle sensor, method of manufacturing the same, and continuous body fluid meter using the same | Pending | 05-Sep-2023 | ||
| EP-4209246-A1 | Method of manufacturing of a particle-attached microneedle | Active | 07-Jan-2022 | ||
| EP-4209246-B1 | Method of manufacturing of a particle-attached microneedle | Active | 07-Jan-2022 | ||
| JP-2023101406-A | Particle adhesion type microneedle and manufacturing method thereof | Active | 07-Jan-2022 | A61M37/0015 |
QuadMedicine Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
QuadMedicine Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
QuadMedicine FAQs
-
When was QuadMedicine founded?
QuadMedicine was founded in 2016.
-
Where is QuadMedicine headquartered?
QuadMedicine is headquartered in Seongnam, South Korea.
-
What is the size of QuadMedicine?
QuadMedicine has 86 total employees.
-
What industry is QuadMedicine in?
QuadMedicine’s primary industry is Drug Delivery.
-
Is QuadMedicine a private or public company?
QuadMedicine is a Public company.
-
What is QuadMedicine’s stock symbol?
The ticker symbol for QuadMedicine is 464490.
-
What is the current stock price of QuadMedicine?
As of 13-Nov-2026 the stock price of QuadMedicine is $2.96.
-
What is the current market cap of QuadMedicine?
The current market capitalization of QuadMedicine is $33.5M.
-
What is QuadMedicine’s current revenue?
The trailing twelve month revenue for QuadMedicine is $6.82M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
